Patent AnalyticsExaminers
Menu

Application

19610833 · CD40 ANTAGONIST OR CD154 ANTAGONIST FOR USE IN MITIGATING IMMUNE RESPONSES IN PROTEIN AND GENE THERAPIES

Filed 2026-07-30 · Pending The official file ↗ · Art unit · Clark+Elbing LLP

Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in